Riskpilot← Back to searchSign inGet full accessIDEXX LABORATORIES NORGE AS
ASActiveOrg 997712196Wergelandsveien 7, 0167 OsloResearch and experimental development on natural sciences and engineering · NACE 7210Est. 201110 employees
Revenue 2024
NOK 16,6M
+18% vs 2023
EBITDA margin
23.7%
+37% vs 2023
Equity ratio
44.6%
Financial strength
Net profit 2024
NOK 3M
+38% vs 2023
| Revenue | NOK 16,6M | +18% |
| EBITDA | NOK 3,9M | +37% |
| Net profit | NOK 3M | +38% |
| Total assets | NOK 40M | +28% |
| Equity | NOK 17,8M | +20% |
| Employees | 10 | — |
Legal name
IDEXX LABORATORIES NORGE AS
Org number
997712196
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
13. desember 2011
Share capital
NOK 120 000
Employees
10 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Forskning, utvikling, produksjon, markedsføring, salg og distribusjon av produkter og tjenesteyting innen områdene veterinærvitenskap, næringsmidler, naturmiljø og helse, herunder å utvikle, produsere, distribuere, markedsføre og selge diagnostiske produkter, tester, utstyr, tilbehør og relaterte tjenester på det menneskelige felt som kan brukes på eller brukes i menneskekroppen (in vitro), samt annen virksomhet i tilknytning til dette, herunder deltakelse i andre selskaper.
Address
Wergelandsveien 7, 0167 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 87 258 | 102 548 | 12 925 | 14 077 | 16 587 |
| Staff expenses | −0 | −4 486 | −6 219 | −6 641 | −8 369 |
| EBITDA | 2 177 | 2 064 | 2 439 | 2 859 | 3 928 |
| Depreciation & amort. | −489 | −376 | −214 | −84 | −49 |
| EBIT | 1 688 | 1 688 | 2 225 | 2 776 | 3 879 |
| Net financials | −20 | 7 | −16 | 15 | −28 |
| Profit before tax | 1 669 | 1 695 | 2 209 | 2 791 | 3 852 |
| Tax | 371 | 378 | 496 | 629 | 858 |
| Net profit | 1 298 | 1 318 | 1 713 | 2 162 | 2 994 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 26 206 | 29 521 | 24 891 | 31 259 | 39 985 |
| Equity | 9 630 | 10 948 | 12 661 | 14 823 | 17 817 |
| Long-term debt | 867 | 786 | 738 | 681 | 0 |
| Short-term debt | 15 709 | 17 787 | 11 492 | 15 755 | 21 549 |
| Total debt | 16 576 | 18 573 | 12 231 | 16 436 | 21 549 |
EBITDA margin
23.7%
This company
15.8%
Market median
+50% vs market
20202024
Equity ratio
44.6%
This company
38.2%
Market median
+17% vs market
20202024
Return on equity
16.8%
This company
18.4%
Market median
+9% vs market
20202024
Net profit margin
18.0%
This company
8.1%
Market median
+122% vs market
20202024
Asset turnover
0.41×
This company
1.12×
Market median
-63% vs market
20202024
Debt / equity
1.24×
This company
0.62×
Market median
-100% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JM Contact Person | Contact Person | 2023 |
| Former (1) | ||
PM Contact Person | Contact Person | 2017 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2021 | |
| Chairman | 2021 | |
| Board of Directors | 2025 | |
| Board of Directors | 2021 | |
| Former (2) | ||
| Board of Directors | 2025 – 2025 | |
| Board of Directors | 2021 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Idexx B.V. | Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of IDEXX LABORATORIES NORGE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Julie Marie Flom | Contact Person | 0 companies |
| Peter Matzen Drachmann | Contact Person | 0 companies |
| Ann-Marie M Määttä | Board of Directors | 0 companies |
| Harold Willem Taal | Board of Directors | 0 companies |
| Jeffery Donn Chadbourne | Chairman | 0 companies |
| Anna Carin Margaretha Lagerlöf | Board of Directors | 0 companies |
| Ann-Marie Määttä | Board of Directors | 0 companies |
| Lily Joann Lu | Board of Directors | 0 companies |